A
References
ASTHO (Association of State and Territorial Health Officials). 2009 (Sept. 28). Operational framework for partnering with pharmacies for administration of 2009 H1N1 vaccine, http://www.astho.org/Display/AssetDisplay.aspx?id=2613 (accessed August 6, 2010).
CDC (Centers for Disease Control and Prevention). 2007 (Nov. 15). Emergency MedKit Evaluation Study Summary, http://www.bt.cdc.gov/agent/anthrax/prep/pdf/medkit-evaluation-summary-2007.pdf (accessed August 2, 2010).
CDC. 2010a. Cities Readiness Initiative, http://www.bt.cdc.gov/cri/ (accessed August 2, 2010).
CDC. 2010b. Strategic National Stockpile, http://www.bt.cdc.gov/stockpile/ (accessed August 2, 2010).
CDC. 2010c. Estimates of deaths associated with seasonal influenza—United States, 1976–2007. Morbidity and Mortality Weekly Report 59(33):1057–1062.
CDC. 2010d. History of flu pandemics, http://www.flu.gov/individualfamily/about/pandemic/history.html (accessed, August 27, 2010).
CDC. 2010e. Coverage under the Public Readiness and Emergency Preparedness (PREP) Act for H1N1 vaccination, http://www.flu.gov/professional/federal/vaccineliability.html (accessed August 25, 2010).
CDC. 2010f. Termination of the Emergency Use Authorization (EUA) of medical products and devices, http://www.cdc.gov/h1n1flu/eua (accessed August 2, 2010).
DHS (Department of Homeland Security). 2008 (Sept. 23). Memorandum from Michael Chertoff to Michael O. Leavitt, Determination Pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act, http://bioterrorism.slu.edu/education/projects/EQUIPPDocs/Chertoff.pdf (accessed August 5, 2010).
FDA (Food and Drug Administration). 2005. SOPP 8010: Administrative procedures for Emergency Use Authorization of medical products, http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ProceduresSOPPs/ucm061226.Htm (accessed August 2, 2010).
FDA. 2007 (July). Emergency Use Authorization of medical products: Guidance, http://www.fda.gov/RegulatoryInformation/Guidances/ucm125127.htm#publication (accessed July 5, 2010).
FDA. 2008 (February 5). Letter of Emergency Use Authorization for the preevent provision and potential use of doxycycline hyclate tablet emergency kits for inhalational anthrax, http://www.fda.gov/downloads/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/UCM107309.pdf (accessed August 5, 2010).
FDA. 2010a. Authorizations of emergency use of certain antiviral drugs–zanamivir and oseltamivir phosphate. Federal Register 74(148):38648–38654.
FDA. 2010b. Authorization of emergency use of the antiviral product peramivir accompanied by emergency use information. Federal Register 74(210):56644–56649.
FDA. 2010c. Authorization of emergency use of certain personal respiratory protection devices. Federal Register 74(148):38644–38648.
FDA. 2010d. Medical devices and flu emergencies: Historical information, http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm (accessed August 25, 2010).
HHS (U.S. Department of Health and Human Services). 2010a. Project BioShield, https://www.medicalcountermeasures.gov/BARDA/bioshield/bioshield.aspx (accessed August 2, 2010).
HHS. 2010b. Public Readiness and Emergency Preparedness Act, http://www.phe.gov/preparedness/legal/prepact/Pages/default.aspx (accessed August 2, 2010).
HRSA (Health Resources and Services Administration). 2010a (May 12). Public Readiness and Emergency Preparedness Act Countermeasures Injury Compensation Program, procedures for submitting a letter of intent to file requests for benefits. Federal Register 75(91):26773–26774.
HRSA. 2010b. Countermeasures Injury Compensation Program, http://www.hrsa.gov/gethealthcare/conditions/countermeasurescomp/index.html (accessed August 25, 2010).
IOM (Institute of Medicine). 2008. Dispensing medical countermeasures for public health emergencies: Workshop summary. Washington, DC: The National Academies Press.
IOM. 2010a. The Public Health Emergency Medical Countermeasures Enterprise: Innovative strategies to enhance products from discovery through approval: Workshop summary. Washington, DC: The National Academies Press.
IOM. 2010b. The 2009 H1N1 influenza vaccination campaign: Summary of a workshop series. Washington, DC: The National Academies Press.
NABP (National Association of Boards of Pharmacy). 2010 (August). Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy, http://www.nabp.net/publications/assets/ModelAct.doc (accessed October 29, 2010).
NACCHO (National Association of County and City Health Officials). 2010 (May). Local health department job losses and program cuts: Findings from January/February 2010 survey, http://www.naccho.org/topics/infrastructure/lhdbudget/upload/Job-Losses-and-Program-Cuts-5-10.pdf (accessed July 2, 2010).
Sherman, S.E., J. Foster, and S. Vaid. 2009. Emergency Use Authorization and the 2009 H1N1 influenza. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 7(3):245–250.
Trust for America’s Health. 2010 (March). Shortchanging America’s health: A state-by-state look at how public health dollars are spent and key state health facts, http://healthyamericans.org/assets/files/TFAH2010Shortchanging05.pdf (accessed July 2, 2010).
The White House. 2009 (December 30). Executive Order—medical countermeasures following a biological attack, http://www.whitehouse.gov/the-press-office/executive-order-medical-countermeasures-following-abiological-attack (accessed August 2, 2010).
